NEW YORK (GenomeWeb News) – South Korean firm Boram Pharm has filed a patent infringement suit in the US against Life Technologies alleging infringement of a patent covering technology for producing recombinant viruses.

The suit was filed last week in the US District Court for the District of Delaware. Boram claims that Life Technologies is infringing US Patent No. 7,319,001, titled "High throughput system for producing recombinant viruses using site-specific recombination." The patent was issued on Jan. 15, 2008 to Neurogenex, which is now owned by Boram.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.